<DOC>
	<DOCNO>NCT01168206</DOCNO>
	<brief_summary>The association nutritional supplement TK3 conventional treatment cancer patient reduce intensity frequency toxic effect side effect cause adjuvant palliative treatment protection healthy tissue , result good quality life .</brief_summary>
	<brief_title>Evaluation TK3 Improving Quality Life Patients With Malignancy Under Chemotherapy</brief_title>
	<detailed_description />
	<criteria>Patient Consent : Informed Consent informed consent sign date patient ( legal representative ) professional obtain consent . Must deliver inclusion . This term must read explained patient . Patients female male , regardless race color.Able ingest oral medication . Patients 3080 year , malignancy , clinical stage III IV chemo hormone therapy . Patients Karnofsky level 60 80. agreement sign Deed Consent . Need use parenteral nutrition . The need food supplement already approve . Inability receive drug orally . Participation another clinical trial involve chemotherapy drug . Women sexually active , agree adhere contraceptive method adopt . Women lactate Any problem condition investigator trial could harmful patient .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>